Keyphrases
Myeloma Cells
100%
Protease Inhibitors
100%
Drug Combination
100%
Multidrug-resistant
100%
Immunomodulatory Drugs (IMiDs)
100%
Greedy Set Cover
100%
Single-cell multi-omics
100%
Myeloma
66%
United States
33%
Greedy Algorithm
33%
Multiple Myeloma
33%
Bone Marrow Cells
33%
Molecular Pathways
33%
Therapeutic Potential
33%
Patient-derived
33%
Screening Tool
33%
Hematological Malignancies
33%
New Therapeutics
33%
Chemotherapy Resistance
33%
Functional Assay
33%
Heat Shock Protein 90 (Hsp90)
33%
Comparative Transcriptome Analysis
33%
R Software
33%
CRISPR/Cas9 Genome Editing
33%
Data-driven Optimization
33%
Dose-limiting Toxicity
33%
Confidence Score
33%
Computational pipeline
33%
Drug Sensitivity
33%
Incurable Disease
33%
Single-cell Proteomics
33%
Ranking Score
33%
Drug-resistant Cancer
33%
Drug Synergy
33%
Single-cell RNA Sequencing (scRNA-seq)
33%
In Vitro Validation
33%
Pharmacogenomics Data
33%
Bulk RNA Sequencing
33%
FK866
33%
17-AAG
33%
Secondary Therapy
33%
CyTOF
33%
NAMPT Inhibitor
33%
Inhibitor Drug
33%
Medicine and Dentistry
Tamsulosin
100%
Multiple Myeloma
100%
Myeloma Cell
100%
Combination Drug
100%
Proteasome Inhibitor
100%
RNA Sequence
66%
Myeloma
66%
Gene Expression Profiling
33%
In Vitro
33%
Cancer
33%
Ex Vivo
33%
Cytometry
33%
Clustered Regularly Interspaced Short Palindromic Repeat
33%
Nicotinamide Phosphoribosyltransferase
33%
Drug Potentiation
33%
Pharmacogenomics
33%
Myeloma Cell Line
33%
Hematopoietic System Malignancy
33%
Immunomodulatory Drug
33%
Daporinad
33%
Diseases
33%
Proteomics
33%
Bone Marrow Cell
33%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Drug
100%
Multiple Myeloma
100%
Myeloma
100%
Proteasome Inhibitor
100%
Tamsulosin
100%
RNA-Sequencing
66%
Chemotherapy
33%
Transcriptome
33%
Hematopoietic System Malignancy
33%
Nicotinamide Phosphoribosyltransferase
33%
Pharmacogenomics
33%
Daporinad
33%
Diseases
33%
Immunology and Microbiology
Multiple Myeloma
100%
Myeloma Cell
100%
Proteasome
100%
Multi-Omics
100%
RNA Sequence
66%
Bone Marrow Cell
33%
Gene Editing
33%
Myeloma Cell Line
33%
Clustered Regularly Interspaced Short Palindromic Repeat
33%
Pharmacogenomics
33%
Immunomodulatory Drug
33%
Drug Potentiation
33%
Nicotinamide Phosphoribosyltransferase
33%
Proteomics
33%
Gene Expression Assay
33%
Biochemistry, Genetics and Molecular Biology
Proteasome Inhibitor
100%
Tamsulosin
100%
Gene Expression Profiling
33%
Genome Editing
33%
Cytometry
33%
CRISPR
33%
RNA Sequence
33%
Nicotinamide Phosphoribosyltransferase
33%
Pharmacogenomics
33%
Drug Potentiation
33%
Proteomics
33%
Bulk RNA Sequencing
33%